Omar Arman, MD, MPH

University at Buffalo

Poster(s):

• P3298 - Long-Term Heart Failure Risk Reduction in Inflammatory Bowel Disease: Biologic vs Non-Biologic Therapy
  Monday, October 27, 2025

  10:30 AM - 4:00 PM MT

• P3299 - Newer Biologics Show Lower Long-Term Cancer Risk Compared to TNF Inhibitors in Inflammatory Bowel Disease: A 5-Year Real-World Analysis
  Monday, October 27, 2025

  10:30 AM - 4:00 PM MT

• P3300 - Biologic Therapy vs Non-Biologics in Reducing Myocardial Infarction Risk in Inflammatory Bowel Disease: A 5-Year Study
  Monday, October 27, 2025

  10:30 AM - 4:00 PM MT

• P3301 - Cardiovascular Outcomes of Biologics vs Non-Biologics Therapy in Inflammatory Bowel Disease: A Propensity-Matched Cohort Analysis
  Monday, October 27, 2025

  10:30 AM - 4:00 PM MT

• P3302 - Real-World Comparison of Infliximab and Adalimumab for Remission Induction in Inflammatory Bowel Disease: A Propensity-Matched Study
  Monday, October 27, 2025

  10:30 AM - 4:00 PM MT

• P3303 - Real-World Comparison of Cardiovascular Safety: Old versus New Biologics in Inflammatory Bowel Disease Over 5 Years
  Monday, October 27, 2025

  10:30 AM - 4:00 PM MT

• P3304 - Newer Biologics Associated With Reduced Hospitalization Compared to TNF Inhibitors in Inflammatory Bowel Disease: A 5-Year Real-World Analysis
  Monday, October 27, 2025

  10:30 AM - 4:00 PM MT

• P3305 - Real-World Comparison of Infliximab and Adalimumab in Achieving Biomarker-Based Remission in Ulcerative Colitis
  Monday, October 27, 2025

  10:30 AM - 4:00 PM MT

• P3306 - Long-Term Risk of Stroke in Inflammatory Bowel Disease Patients: A Comparative Study of Biologic vs Non-Biologic Therapy
  Monday, October 27, 2025

  10:30 AM - 4:00 PM MT

• P3307 - Comparative Impact of Biologic vs Non-Biologic Therapy on Arrhythmia Risk in Inflammatory Bowel Disease: A 5-Year Propensity-Matched Study
  Monday, October 27, 2025

  10:30 AM - 4:00 PM MT

• P3308 - Comparing Infliximab and Adalimumab for Biomarker-Based Remission in Crohn’s Disease: Insights From Real-World Data
  Monday, October 27, 2025

  10:30 AM - 4:00 PM MT

• P3309 - Long-Term Safety of Ustekinumab vs Risankizumab in Biologic-Naive Inflammatory Bowel Disease Patients: Insights From a Retrospective Study
  Monday, October 27, 2025

  10:30 AM - 4:00 PM MT

• P3310 - Real-World Data Reveals Reduced Heart Failure Risk With New Biologics Compared to Old Biologics in Inflammatory Bowel Disease: A 5-Year Comparative Study
  Monday, October 27, 2025

  10:30 AM - 4:00 PM MT

• P3531 - The Effect of Antiplatelet on Outcomes of Endoscopic Upper GI Balloon Dilation
  Monday, October 27, 2025

  10:30 AM - 4:00 PM MT